Table 3.
Comparison of laboratory data of the patients according to the groups
| PCOS group (n=35) | Control group (n=35) | p value | |
|---|---|---|---|
| FBG (mg/dL) | 88.7±9.0 | 81.9±8.0 | 0.002 |
| TC (mg/dL) | 189.2±36.2 | 165.7±38.7 | 0.03 |
| HDL-C (mg/dL) | 46.6±6.9 | 54.1±11.1 | 0.005 |
| LDL-C (mg/dL) | 119.8±32.9 | 97.2±25.8 | 0.008 |
| Triglyceride (mg/dL) | 113.5±57.3 | 85.7±39.5 | 0.03 |
| AST (U/L) | 18.2±6.6 | 15.9±3.5 | 0.09 |
| ALT (U/L) | 19.7±14.1 | 12.8±6.3 | 0.02 |
| Insulin (mIU/L) | 14.4±7.3 | 8.2±4.8 | <0.001 |
| HOMA-IR | 3.3±1.8 | 1.6±1.0 | <0.001 |
| Neprilysin (pg/mL) | 1502.1±1641.2 | 764.6±562.6 | 0.027 |
PCOS: polycystic ovary syndrome, FBG: Fasting blood glucose, TC: Total cholesterol, HDL-C: High density lipoprotein-cholesterol, LDL-C: Low density lipoprotein-cholesterol, AST: aspartate transaminase, ALT: alanine transaminase, HOMA-IR: Homeostasis model assessment.